Table 1.
N = 19 | Median (range) |
---|---|
Age (y) | 38 (26-61) |
Surgery | |
Breast conservation | 3 |
Mastectomy | 16 |
Sentinel node biopsy | 4 |
Axillary lymph node dissection | 15 |
Postmastectomy reconstruction | 12 |
Axillary nodes removed | 16 (2-27) |
Lymph nodes positive | 2 (0-18) |
Systemic therapy | |
Neoadjuvant chemotherapy | 15 |
Adjuvant chemotherapy | 2 |
Doxorubicin | 17 |
HER2-directed therapy | 7 |
Trastuzumab | 7 |
Pertuzumab | 7 |
Hormone therapy | 13 |
Dosimetry | |
Cardiac mean (cGy) | 475 (187-698) |
Cardiac max (cGy) | 2999 (1560-4793) |
Laterality | |
Right | 1 |
Left | 18 |